(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOLC1 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene decreases expression ISO RGD:1354376 6480464 alpha phellandrene results in decreased expression of NOLC1 mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1354376 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOLC1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO RGD:1332150 6480464 1, 2-Dimethylhydrazine results in increased expression of NOLC1 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1354376 6480464 Dinitrochlorobenzene binds to NOLC1 protein CTD PMID:32991956 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NOLC1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of NOLC1 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:1354376 6480464 Estradiol results in increased expression of NOLC1 mRNA CTD PMID:23019147 more ... 17beta-estradiol multiple interactions ISO RGD:1354376 6480464 EGF protein promotes the reaction [Estradiol results in increased expression of NOLC1 mRNA] CTD PMID:24758408 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1332150 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332150 6480464 Tetrachlorodibenzodioxin results in decreased expression of NOLC1 mRNA CTD PMID:19770486 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NOLC1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332150 6480464 Tetrachlorodibenzodioxin affects the expression of NOLC1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NOLC1 protein CTD PMID:16548065 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332150 6480464 Tetrachlorodibenzodioxin results in increased expression of NOLC1 mRNA CTD PMID:20159946 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1354376 6480464 2 more ... CTD PMID:19031421 2,4-diaminotoluene increases expression ISO RGD:1332150 6480464 2, 4-diaminotoluene results in increased expression of NOLC1 mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NOLC1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of NOLC1 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression ISO RGD:1332150 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NOLC1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1354376 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NOLC1 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of NOLC1 mRNA CTD PMID:21346803 4-phenylbutyric acid decreases expression ISO RGD:1354376 6480464 4-phenylbutyric acid results in decreased expression of NOLC1 mRNA CTD PMID:14583596 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of NOLC1 mRNA CTD PMID:12800193 acrolein multiple interactions ISO RGD:1354376 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOLC1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOLC1 mRNA CTD PMID:32699268 afimoxifene multiple interactions ISO RGD:1354376 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of NOLC1 mRNA] CTD PMID:21233418 aflatoxin B1 increases expression ISO RGD:1354376 6480464 Aflatoxin B1 results in increased expression of NOLC1 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1354376 6480464 Tretinoin results in decreased expression of NOLC1 mRNA CTD PMID:16054129 more ... alpha-phellandrene decreases expression ISO RGD:1354376 6480464 alpha phellandrene results in decreased expression of NOLC1 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:1354376 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOLC1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOLC1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NOLC1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1354376 6480464 Antirheumatic Agents results in decreased expression of NOLC1 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:1354376 6480464 Arsenic Trioxide results in decreased expression of NOLC1 mRNA CTD PMID:20458559 ATP multiple interactions ISO RGD:1354376 6480464 Adenosine Triphosphate affects the reaction [Doxorubicin binds to NOLC1 protein] CTD PMID:17129415 atrazine increases expression ISO RGD:1354376 6480464 Atrazine results in increased expression of NOLC1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1332150 6480464 Benzo(a)pyrene results in decreased expression of NOLC1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1354376 6480464 Benzo(a)pyrene results in decreased methylation of NOLC1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1354376 6480464 Benzo(a)pyrene results in increased expression of NOLC1 mRNA, Benzo(a)pyrene results in increased expression of NOLC1 protein CTD PMID:26238291 , PMID:33278487 bis(2-ethylhexyl) adipate decreases expression EXP 6480464 dioctyl adipate results in decreased expression of NOLC1 mRNA CTD PMID:16493179 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NOLC1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1354376 6480464 bisphenol A results in decreased expression of NOLC1 protein CTD PMID:34186270 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NOLC1 mRNA CTD PMID:30816183 bisphenol F increases expression ISO RGD:1354376 6480464 bisphenol F results in increased expression of NOLC1 protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of NOLC1 protein CTD PMID:28903499 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of NOLC1 mRNA CTD PMID:12800193 caffeine affects phosphorylation ISO RGD:1354376 6480464 Caffeine affects the phosphorylation of NOLC1 protein CTD PMID:35688186 carbon nanotube increases expression ISO RGD:1332150 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chromium(6+) affects expression ISO RGD:1332150 6480464 chromium hexavalent ion affects the expression of NOLC1 mRNA CTD PMID:28472532 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of NOLC1 mRNA CTD PMID:17602206 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOLC1 mRNA CTD PMID:17602206 copper atom multiple interactions ISO RGD:1332150 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOLC1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1332150 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOLC1 mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO RGD:1354376 6480464 Copper Sulfate results in increased expression of NOLC1 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1354376 6480464 coumarin affects the phosphorylation of NOLC1 protein CTD PMID:35688186 coumestrol increases expression ISO RGD:1354376 6480464 Coumestrol results in increased expression of NOLC1 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1354376 6480464 Cyclosporine results in increased expression of NOLC1 mRNA CTD PMID:20106945 cyclosporin A increases methylation ISO RGD:1354376 6480464 Cyclosporine results in increased methylation of NOLC1 promoter CTD PMID:27989131 deguelin decreases expression ISO RGD:1354376 6480464 deguelin results in decreased expression of NOLC1 mRNA CTD PMID:33512557 deoxynivalenol increases expression ISO RGD:1354376 6480464 deoxynivalenol results in increased expression of NOLC1 mRNA CTD PMID:24247028 diarsenic trioxide decreases expression ISO RGD:1354376 6480464 Arsenic Trioxide results in decreased expression of NOLC1 mRNA CTD PMID:20458559 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NOLC1 mRNA CTD PMID:16493179 , PMID:21266533 dibutyl phthalate decreases expression ISO RGD:1332150 6480464 Dibutyl Phthalate results in decreased expression of NOLC1 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos increases expression ISO RGD:1354376 6480464 dicrotophos results in increased expression of NOLC1 mRNA CTD PMID:28302478 diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of NOLC1 mRNA CTD PMID:16493179 dioxygen multiple interactions ISO RGD:1332150 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOLC1 mRNA CTD PMID:30529165 doxorubicin multiple interactions ISO RGD:1354376 6480464 Adenosine Triphosphate affects the reaction [Doxorubicin binds to NOLC1 protein] CTD PMID:17129415 doxorubicin decreases expression ISO RGD:1354376 6480464 Doxorubicin results in decreased expression of NOLC1 mRNA CTD PMID:29803840 doxorubicin affects binding ISO RGD:1354376 6480464 Doxorubicin binds to NOLC1 protein CTD PMID:17129415 elemental selenium multiple interactions ISO RGD:1354376 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA CTD PMID:19244175 epoxiconazole decreases expression ISO RGD:1332150 6480464 epoxiconazole results in decreased expression of NOLC1 mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1332150 6480464 Ethanol affects the splicing of NOLC1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1354376 6480464 Ethyl Methanesulfonate results in decreased expression of NOLC1 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of NOLC1 mRNA CTD PMID:30307764 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of NOLC1 mRNA CTD PMID:23962444 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NOLC1 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NOLC1 mRNA CTD PMID:24793618 hexadecanoic acid increases phosphorylation ISO RGD:1354376 6480464 Palmitic Acid results in increased phosphorylation of NOLC1 protein CTD PMID:28073184 hydrogen peroxide affects expression ISO RGD:1354376 6480464 Hydrogen Peroxide affects the expression of NOLC1 mRNA CTD PMID:20044591 ivermectin decreases expression ISO RGD:1354376 6480464 Ivermectin results in decreased expression of NOLC1 protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO RGD:1354376 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOLC1 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1354376 6480464 Lipopolysaccharides results in increased expression of NOLC1 mRNA CTD PMID:35811015 menadione affects expression ISO RGD:1354376 6480464 Vitamin K 3 affects the expression of NOLC1 mRNA CTD PMID:20044591 methotrexate affects expression ISO RGD:1332150 6480464 Methotrexate affects the expression of NOLC1 mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:1354376 6480464 Methyl Methanesulfonate results in decreased expression of NOLC1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1354376 6480464 methylmercuric chloride results in increased expression of NOLC1 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO RGD:1332150 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NOLC1 protein CTD PMID:26558463 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOLC1 mRNA CTD PMID:17602206 nickel atom increases expression ISO RGD:1354376 6480464 Nickel results in increased expression of NOLC1 mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NOLC1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1354376 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOLC1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1332150 6480464 Acetaminophen affects the expression of NOLC1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NOLC1 mRNA CTD PMID:32479839 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NOLC1 mRNA CTD PMID:32680482 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of NOLC1 mRNA CTD PMID:19162173 phorbol 13-acetate 12-myristate increases expression ISO RGD:1354376 6480464 Tetradecanoylphorbol Acetate results in increased expression of NOLC1 mRNA CTD PMID:19031421 phorone affects expression EXP 6480464 phorone affects the expression of NOLC1 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:1332150 6480464 pirinixic acid results in increased expression of NOLC1 mRNA CTD PMID:18301758 piroxicam increases expression ISO RGD:1354376 6480464 Piroxicam results in increased expression of NOLC1 mRNA CTD PMID:21858171 potassium chromate increases expression ISO RGD:1354376 6480464 potassium chromate(VI) results in increased expression of NOLC1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1354376 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOLC1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1332150 6480464 Pregnenolone Carbonitrile results in increased expression of NOLC1 mRNA CTD PMID:28903501 resveratrol decreases expression ISO RGD:1332150 6480464 resveratrol results in decreased expression of NOLC1 protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:1354376 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of NOLC1 mRNA CTD PMID:23557933 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NOLC1 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1354376 6480464 Rotenone results in decreased expression of NOLC1 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1354376 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOLC1 mRNA CTD PMID:35811015 selenium atom multiple interactions ISO RGD:1354376 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1354376 6480464 Silicon Dioxide analog results in increased expression of NOLC1 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1354376 6480464 sodium arsenite results in increased expression of NOLC1 mRNA CTD PMID:21457566 sodium arsenite decreases expression ISO RGD:1354376 6480464 sodium arsenite results in decreased expression of NOLC1 mRNA CTD PMID:20886546 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of NOLC1 mRNA CTD PMID:25993096 sunitinib decreases expression ISO RGD:1354376 6480464 Sunitinib results in decreased expression of NOLC1 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:1354376 6480464 T-2 Toxin results in increased expression of NOLC1 mRNA CTD PMID:34581912 temozolomide increases expression ISO RGD:1354376 6480464 Temozolomide results in increased expression of NOLC1 mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:1332150 6480464 Carbon Tetrachloride results in increased expression of NOLC1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NOLC1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOLC1 mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1354376 6480464 Thapsigargin results in decreased expression of NOLC1 mRNA CTD PMID:24247028 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of NOLC1 protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NOLC1 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NOLC1 mRNA CTD PMID:25729387 Tributyltin oxide decreases expression ISO RGD:1354376 6480464 bis(tri-n-butyltin)oxide results in decreased expression of NOLC1 mRNA CTD PMID:24247028 trimellitic anhydride increases expression ISO RGD:1332150 6480464 trimellitic anhydride results in increased expression of NOLC1 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of NOLC1 mRNA CTD PMID:30589522 Triptolide increases expression ISO RGD:1332150 6480464 triptolide results in increased expression of NOLC1 mRNA CTD PMID:32835833 tungsten decreases expression ISO RGD:1332150 6480464 Tungsten results in decreased expression of NOLC1 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1332150 6480464 Valproic Acid results in decreased expression of NOLC1 mRNA CTD PMID:19136453 , PMID:21427059 valproic acid increases expression ISO RGD:1354376 6480464 Valproic Acid results in increased expression of NOLC1 mRNA CTD PMID:23179753 valproic acid increases methylation ISO RGD:1354376 6480464 Valproic Acid results in increased methylation of NOLC1 gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NOLC1 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NOLC1 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1354376 6480464 Vitamin E results in decreased expression of NOLC1 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1354376 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA CTD PMID:19244175